MedPAC Revisits Open Payments; Considers Expanding Reporting Requirements
Last week, MedPAC (the Medicare Payments Advisory Commission), an important advisory committee to congress, held their…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Sen. Bernie Sanders Announces “Prescription Drug Affordability Act of…
Pushes for Lower Drug Prices Through Variety of Measures Including Drug Pricing Transparency; Allowing Part D Negotiations;…
Penalized for “On-Label” Marketing? In Wake of Amarin, Pacira…
Last week, Pacira Pharmaceuticals, Inc. filed a lawsuit against the Food and Drug Administration (FDA) seeking to…
Physician Payments Sunshine Act: Open Payments Infographic
Potomac River Partners recently put together an infographic of CMS Open Payments data, which provides an interesting look at the…
A Multitude of Challenges Face Life Sciences Companies
Life science companies continue to face a number of challenges in today’s business climate. M&A activity, economic trends, and…
Genzyme Corp. Pays $32.5 Million To Resolve Criminal Charges Related to Med…
Last week, Genzyme Corporation, a wholly-owned subsidiary of the French company Sanofi, agreed to pay $32.5 million to…
HHS Proposes Big Changes to “Common Rule” Policy for Protection…
Today, the Department of Health and Human Services (HHS) along with 15 other federal agencies and departments officially…
Education Positively Impacts Safe Opioid Prescribing Among Clinicians
A recent study in the journal Pain Medicine, looking at the impact of continuing medical education (CME) on opioid…
Compliance Conference Calendar
Life science compliance conferences are an important way for compliance professionals and healthcare attorneys to stay on top of…
EFPIA Files Complaint Against French Law Promoting Off-Label Avastin Use
Earlier this week, EFPIA, Europe's pharmaceutical industry association, announced it had filed a complaint with the…